Ardigen

Krakow, Poland Founded: 2015 • Age: 11 yrs
Provider of AI-driven solutions for drug discovery and clinical development

About Ardigen

Ardigen is a company based in Krakow (Poland) founded in 2015. Ardigen offers products and services including Ardigen phenAID, Ardigen biologics discovery platform, and Bioinformatics Workflows. Ardigen operates in a competitive market with competitors including GSK, Avidity Biosciences, Strand Life Sciences, Sutro Biopharma and Antheia, among others.

  • Headquarter Krakow, Poland
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website ardigen.com
  • Social LinkedIn X Facebook YouTube
  • Legal Name Ardigen Spółka Akcyjna
Key Metrics

Products & Services of Ardigen

Ardigen offers a comprehensive portfolio of products and services, including Ardigen phenAID, Ardigen biologics discovery platform, and Bioinformatics Workflows.

Ardigen phenAID
Phenotypic Profiling Platform

Platform for discovering drug candidates using AI and imaging data.

Ardigen biologics discovery platform
Biologics Optimization Tool

AI algorithms for designing and evaluating novel biologics.

Bioinformatics Workflows
Data Analysis Service

Tools to transform biological datasets into actionable insights.

Apps and channels of Ardigen

its YouTube channel Ardigen SA has 103 subscribers and 30 videos.

Ardigen SA
YouTube 103 subscribers 30 videos Science & Technology
Open channel

Videos from Ardigen

The most watched videos on Ardigen's YouTube channel, Ardigen SA (103 subscribers). Click a video to play it here.

Code Against Cancer - Anna Kościółek & Giovanni Mazzocco
1.3K views
What motivates our employees to work at Ardigen?
793 views
Code Against Cancer - Agnieszka Rasińska
611 views
Livia Legg interview during the Discovery Europe 2024
221 views

More on Ardigen SA.

Funding Insights of Ardigen

  • Total Rounds 2
  • Investors Count 1

All 2 funding rounds of Ardigen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2021–Grant––
Sep 2020–Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in Ardigen

Ardigen has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include NCBR.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government programs access and development services are provided by NCBR.
2009ncbr.gov.plPoland
Premium access

Investor details for Ardigen

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Ardigen

77 people are tracked at Ardigen (16 in leadership, 1 in board & advisors, 60 in team).

NameRoleGroup
Janusz Homa
CEO & Co-FounderLeadership
Agnieszka Plociennikowska
Program DirectorLeadership
Jan Kaczmarczyk
Director of Data Science | Lead Data Scientist in ImmunologyLeadership
Anna Kościółek
Head of People and CultureLeadership
Marek Kudla
Director Of BioinformaticsLeadership
Piotr Faba
Director Of Software EngineeringLeadership
Michał Warchoł
CTOLeadership
Lukasz Pawel Nowak
Chief Operating Officer & Board MemberLeadership
Sean Melville
Business Development DirectorLeadership
Livia Legg
Chief Commercial OfficerLeadership
Dawid Rymarczyk
Director Of AI | Lead Data ScientistLeadership
Agata Miezaniec, PhD
Business Development DirectorLeadership
Maciej Jasinski
Director Of BiologicsLeadership
Marek Piatek
Executive Director of ScienceLeadership
Nasim J.
Director Of Morphological ProfilingLeadership
Aleksandra Kolcon
Talent Acquisition PartnerLeadership
Pawel Przewiezlikowski
President of the Supervisory BoardBoard & advisors
Małgorzata Oleszycka
Business Development AssistantTeam
Rafał Wałkowski
Team LeaderTeam
Magdalena Otrocka
Lead Molecular BiologistTeam

57 more people are available in the full profile.

Premium access

Complete people profiles for Ardigen

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Ardigen

3 dated milestones of Ardigen across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Ardigen is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Grant,.

Competitors of Ardigen

Ardigen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Strand Life Sciences, Sutro Biopharma and Antheia, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
gsk.com1715Brentford, United Kingdom–90,913
Developer of pharmaceuticals and vaccines for various therapeutic areas
aviditybiosciences.com2012San Diego, United States$142.54M253
Antibody-siRNA complexes are developed for cancer treatment.
strandls.com2000Bengaluru, India$34.88M532
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
sutrobio.com2003United States$171.85M235
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
antheia.bio2013Palo Alto, United States$152.37M50
Yeast cells are genetically engineered to produce medicinal products.
vividion.com2016Oceanside, United States$270.5M123
Developing novel drugs based on a proteome-wide ligand and target discovery platform
synthego.com2012Redwood, United States$459.75M–
CRISPR-engineered cell and gene therapies are developed for research applications.
korrobio.com2018Cambridge, United States$4M77
RNA-editing technologies are provided for precision medicine applications.
univercells.com2013Charleroi, Belgium$150.64M87
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
savarapharma.com2008Austin, United States$67.82M37
Therapeutics for rare respiratory diseases are developed by Savara Pharma.
Premium access

Detailed competitors of Ardigen

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Ardigen

The website of Ardigen (ardigen.com) receives about 7K visits a month.

  • Monthly visits
    7K

    ▼ 19.5% vs previous month

Latest news on Ardigen

Premium access

Complete news archive for Ardigen

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Ardigen

10 companies that operate in the same segment as Ardigen (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts
2016Bengaluru, Karnataka, IndiaUSD 713.57 M––
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M––
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M233
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M––
Tech-enabled mental health solutions for employers are provided.
2016New York, New York, United StatesUSD 508.73 M––
App-based health insurance is offered to individuals and businesses.
2016Paris, FranceUSD 863.12 M––
Virtual care programs for managing chronic diseases are provided.
2011San Francisco, California, United StatesUSD 450.12 MUSD 260.21 M–
AI-driven EMR and practice management software is delivered for clinics.
2010Boca Raton, Florida, United StatesUSD 329.17 M––
Cloud-based administrative tools for healthcare providers are offered.
1997Watertown, United StatesUSD 40 M––
Membership-based primary care platform is offered for employees and consumers.
2007San Francisco, California, United StatesUSD 402.56 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Ardigen

Ardigen was founded in 2015 and raised its 1st funding round 5 years after it was founded.

Ardigen is headquartered in Krakow, Poland. It is registered at Krakow, Lesser Poland Voivodeship, Poland.

Provider of AI-driven solutions for drug discovery and clinical development. The company offers services spanning target identification, small molecule design, biologics development, and clinical data analysis. It delivers bioinformatics, data management, and software engineering to streamline research. The company provides custom algorithms and models for accurate predictions in drug programs.

Ardigen's top competitors include Strand Life Sciences, Sutro Biopharma and Synthego.

Ardigen offers Ardigen phenAID, Ardigen biologics discovery platform, and Bioinformatics Workflows.

Ardigen has 1 investor. Key investors include NCBR.

Ardigen operates through Ardigen Spółka Akcyjna.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available